Metastatic Retinoblastoma. Clinical Features, Treatment, and Prognosis

Ophthalmology

Volumn 113, Issue 9, 2006, Pages 1558-1566

  Gündüz, Kaan ^a   Müftüoglu, Orkun ^a   Günalp, Ilhan ^a   Ünal, Emel ^a   Taçyildiz, Nurdan ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; BONE SCINTISCANNING; BRAIN; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; ENUCLEATION; EVISCERATION; EYE BIOPSY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IRRADIATION; LUMBAR PUNCTURE; METASTASIS; NEPHROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE; OPTIC NERVE LESION; ORBIT; OTOTOXICITY; PRIORITY JOURNAL; PROGNOSIS; RETINOBLASTOMA; SURVIVAL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE NEOPLASMS; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; EYE ENUCLEATION; EYE EVISCERATION; FEMALE; HUMANS; INFANT; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM INVASIVENESS; OPTIC NERVE NEOPLASMS; ORBITAL NEOPLASMS; PROGNOSIS; RADIOTHERAPY, HIGH-ENERGY; RETINAL NEOPLASMS; RETINOBLASTOMA; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 33747890610     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2006.03.039     Document Type: Article

References (37)

1. Magramm I., Abramson D.H., and Ellsworth R.M. Optic nerve involvement in retinoblastoma. Ophthalmology 96 (1989) 217-222
2. Rootman J., Ellsworth R.M., Hofbauer J., and Kitchen D. Orbital extension of retinoblastoma. a clinicopathological study. Can J Ophthalmol 13 (1978) 72-80
3. Finger P.T., Harbour J.W., and Karcioglu Z.A. Risk factors for metastasis in retinoblastoma. Surv Ophthalmol 47 (2002) 1-16
4. Finger P.T., Czechonska G., Demirci H., and Rausen A. Chemotherapy for retinoblastoma. a current topic. Drugs 58 (1999) 983-996
5. Namouni F., Doz F., Tanguy M.L., et al. High-dose chemotherapy with carboplatin, etoposide, and cyclophosphamide followed by haematopoietic stem cell rescue in patients with high-risk retinoblastoma. a SFOP and SFGM study. Eur J Cancer 33 (1997) 2368-2375
6. Antoneli C.B., Steinhorst F., de Cassia Braga Ribeiro K., et al. Extraocular retinoblastoma. a 13-year experience. Cancer 98 (2003) 1292-1298
7. Chantada G., Fandiño A., Casak S., et al. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol 40 (2003) 158-161
8. Günalp I., Gündüz K., and Arslan Y. Retinoblastoma in Turkey. diagnosis and clinical characteristics. Ophthalmic Genet 17 (1996) 21-27
9. Leal-Leal C., Flores-Rojo M., Medina-Sanson A., et al. A multicentre report from the Mexican Retinoblastoma Group. Br J Ophthalmol 88 (2004) 1074-1077
10. Schvartzman E., Chantada G., Fandiño A., et al. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 14 (1996) 1532-1536
11. Abu-Ghosh A.M., Krailo M.D., Goldman S.C., et al. Ifosfamide, carboplatin and etoposide in children with poor-risk relapsed Wilms' tumor. a Children's Cancer Group report. Ann Oncol 13 (2002) 460-469
12. Sanders B.M., Draper G.J., and Kingston J.E. Retinoblastoma in Great Britain 1969-80. incidence, treatment and survival. Br J Ophthalmol 72 (1988) 576-583
13. Kopelman J.E., McLean I.W., and Rosenberg S.H. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 94 (1987) 371-377
14. Baez K.A., Ulbig M.W., Cater J., et al. Iris neovascularization, increased intraocular pressure and vitreous hemorrhage as risk factors for invasion of the optic nerve and choroid in children with retinoblastoma. [in German]. Ophthalmologe 91 (1994) 796-800
15. Messmer E.P., Heinrich T., Hopping W., et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 98 (1991) 136-141
16. Wang A.G., Hsu W.M., Hsia W.W., et al. Clinicopathologic factors related to metastasis in retinoblastoma. J Pediatric Ophthalmol Strabismus 38 (2001) 166-171
17. Materin M.A., Shields C.L., Shields J.A., and Eagle Jr. R.C. Diffuse infiltrating retinoblastoma simulating uveitis in a 7-year-old boy. Arch Ophthalmol 118 (2000) 442-443
18. Bhatnagar R., and Vine A.K. Diffuse infiltrating retinoblastoma. Ophthalmology 98 (1991) 1657-1661
19. Abramson D.H., Servodido C.A., De Lillo A.R., et al. Recurrence of unilateral retinoblastoma following radiation therapy. Ophthalmic Genet 15 (1994) 107-113
20. Shields C.L., Piccone M.R., Shields J.A., et al. Mushroom-shaped choroidal recurrence of retinoblastoma 25 years after therapy. Arch Ophthalmol 120 (2002) 844-846
21. Goto H., Kousaka A., Takano S., and Usui M. Recurrence of retinoblastoma 12 years after brachytherapy. Am J Ophthalmol 134 (2002) 773-775
22. Messmer E.P., Sauerwein W., Heinrich T., et al. New and recurrent tumor foci following local treatment as well as external beam radiation in eyes of patients with hereditary retinoblastoma. Graefes Arch Clin Exp Ophthalmol 228 (1990) 426-431
23. Shields C.L., Honavar S.G., Shields J.A., et al. Vitrectomy in eyes with unsuspected retinoblastoma. Ophthalmology 107 (2000) 2250-2255
24. Khelfaoui F., Validire P., Auperin A., et al. Histopathologic risk factors in retinoblastoma. a retrospective study of 172 patients treated in a single institution. Cancer 77 (1996) 1206-1213
25. Shields C.L., Shields J.A., Baez K.A., et al. Choroidal invasion of retinoblastoma. metastatic potential and clinical risk factors. Br J Ophthalmol 77 (1993) 544-548
26. Shields C.L., Shields J.A., Baez K., et al. Optic nerve invasion of retinoblastoma. metastatic potential and clinical risk factors. Cancer 73 (1994) 692-698
27. Honavar S.G., Singh A.D., Shields C.L., et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 120 (2002) 923-931
28. Zelter M., Damel A., Gonzales G., and Schwartz L. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer 68 (1991) 1685-1690
29. Doz F., Neuenschwander S., Plantaz D., et al. Etoposide and carboplatin in extraocular retinoblastoma. a study by the Societe Francaise d'Oncologie Pediatrique. J Clin Oncol 13 (1995) 902-909
30. Hungerford J. Factors influencing metastasis in retinoblastoma. Br J Ophthalmol 77 (1993) 541
31. Hungerford J., Kingston J., and Plowman N. Orbital recurrence of retinoblastoma. Ophthalmic Paediatr Genet 8 (1987) 63-68
32. Goble R.R., McKenzie J., Kingston J.E., et al. Orbital recurrence of retinoblastoma successfully treated by combined therapy. Br J Ophthalmol 74 (1990) 97-98
33. Pratt C.B., Fontanesi J., Chenaille P., et al. Chemotherapy for extraocular retinoblastoma. Pediatr Hematol Oncol 11 (1994) 301-309
34. Pratt C.B. Use of chemotherapy for retinoblastoma. Med Pediatr Oncol 31 (1998) 531-533
35. Pratt C.B., Douglass E.C., Etcubanas E.L., et al. Ifosfamide in pediatric malignant solid tumors. Cancer Chemother Pharmacol 24 suppl (1989) S24-S27
36. Kung F.H., Desai S.J., Dickerman J.D., et al. Ifosfamide/carboplatin/etoposide (ICE) for recurrent malignant solid tumors of childhood. a Pediatric Oncology Group Phase I/II study. J Pediatr Hematol Oncol 17 (1995) 265-269
37. Rodriguez-Galindo C., Wilson M.W., Haik B.G., et al. Treatment of metastatic retinoblastoma. Ophthalmology 110 (2003) 1237-1240